Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “T Cell Non-Hodgkin's Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT05403450
What this trial is testing

Tolinapant in Combination With Oral Decitabine/Cedazuridine and Oral Decitabine/Cedazuridine Alone in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma (R/R PTCL)

Who this might be right for
Relapsed/Refractory Peripheral T-cell Lymphoma
Taiho Oncology, Inc. 33
Early research (Phase 1)Active Not RecruitingNCT04732845
What this trial is testing

Human AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Lymphoid Malignancies

Who this might be right for
Non Hodgkin LymphomaAcute Lymphoblastic LeukemiaChronic Lymphocytic Leukemia
Benjamin Tomlinson 18
Early research (Phase 1)Active Not RecruitingNCT03602157
What this trial is testing

Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL

Who this might be right for
LymphomaImmune System DiseasesImmunoproliferative Disorders+10 more
UNC Lineberger Comprehensive Cancer Center 43
Early research (Phase 1)Looking for participantsNCT06313957
What this trial is testing

LUCAR-20SP in Subjects With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
Relapsed B-cell Non-Hodgkin LymphomaRefractory B-cell Non-Hodgkin Lymphoma
Peking University Cancer Hospital & Institute 42
Early research (Phase 1)Ended earlyNCT00127101
What this trial is testing

An Investigational Study of a Histone Deacetylase (HDAC) Inhibitor Plus Targretin in Cutaneous T-Cell Lymphoma Patients (0683-016)(TERMINATED)

Who this might be right for
Lymphoma
Merck Sharp & Dohme LLC 23
Testing effectiveness (Phase 2)Study completedNCT03310619
What this trial is testing

A Safety and Efficacy Trial of JCAR017 Combinations in Subjects With Relapsed/Refractory B-cell Malignancies

Who this might be right for
Lymphoma, Non-HodgkinLymphoma, Large B-Cell, DiffuseLymphoma, Follicular
Celgene 62
Testing effectiveness (Phase 2)UnknownNCT03853044
What this trial is testing

Study Evaluating the Safety and Efficacy of C-CHOP in Untreated Subjects With Angioimmunoblastic T Cell Lymphoma

Who this might be right for
Angioimmunoblastic T-cell Lymphoma
Ruijin Hospital 23
Testing effectiveness (Phase 2)UnknownNCT04484506
What this trial is testing

Pegaspargase-COEP Chemotherapy Combined With Radiotherapy for Extra-nodal NK/T Cell Lymphoma

Who this might be right for
NK/T Cell Lymphoma Nos
Peking University 150
Early research (Phase 1)Study completedNCT00771472
What this trial is testing

Vorinostat (MK-0683) Phase I Study in Cutaneous T-Cell Lymphoma (CTCL) Patients (MK-0683-089 EXT1)

Who this might be right for
Lymphoma
Merck Sharp & Dohme LLC 10
Testing effectiveness (Phase 2)Study completedNCT01908777
What this trial is testing

Multicenter Study of High Dose Chemotherapy With Autologous Stem Cell Transplant Followed by Maintenance Therapy With Romidepsin for the Treatment of T Cell Non-Hodgkin Lymphoma

Who this might be right for
T Cell Non-Hodgkin Lymphoma
Memorial Sloan Kettering Cancer Center 47
Early research (Phase 1)Looking for participantsNCT05544019
What this trial is testing

Study of SGR-1505 in Mature B-Cell Neoplasms

Who this might be right for
Mature B-Cell NeoplasmNon Hodgkin LymphomaDLBCL+23 more
Schrödinger, Inc. 98
Early research (Phase 1)Study completedNCT01748721
What this trial is testing

MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+43 more
Morphotek 27
Not applicableStudy completedNCT00060021
What this trial is testing

Acupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell Transplantation

Who this might be right for
Cancer
National Cancer Institute (NCI)
Not applicableStudy completedNCT00964821
What this trial is testing

Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
City of Hope Medical Center 459
Testing effectiveness (Phase 2)Ended earlyNCT00290706
What this trial is testing

A Phase I/II Trial of VELCADE & Gemcitabine for Patients With Relapsed or Refractory Aggressive B- and T-cell Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Northwestern University 32
Not applicableStudy completedNCT02788916
What this trial is testing

A Retrospective Study of Clinical, Phenotypic and Genetic Factors of Peripheral T-Cell Lymphomas

Who this might be right for
Lymphoma, T-Cell, Peripheral
Takeda 198
Testing effectiveness (Phase 2)Looking for participantsNCT06238648
What this trial is testing

Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy

Who this might be right for
Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedPrimary Mediastinal Large B-Cell LymphomaTransformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma
Academic and Community Cancer Research United 120
Not applicableNot Yet RecruitingNCT06721598
What this trial is testing

An Extension Study to Evaluate the Safety and Efficacy of an Anti-CD19 CAR-T Product in Patients with B-cell Lymphoproliferative Disorders

Who this might be right for
Non-Hodgkin Lymphoma, B-cellAcute Lymphoblastic Leukemia ALL
National Research Center for Hematology, Russia 60
Testing effectiveness (Phase 2)Study completedNCT00806767
What this trial is testing

Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+3 more
Institut Paoli-Calmettes 82
Not applicableStudy completedNCT00376922
What this trial is testing

Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+7 more
Wake Forest University Health Sciences 65
Next Page